Connable Office Inc. Has $410,000 Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Connable Office Inc. grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 16.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,150 shares of the medical instruments supplier’s stock after buying an additional 2,138 shares during the quarter. Connable Office Inc.’s holdings in DENTSPLY SIRONA were worth $410,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. UMB Bank n.a. lifted its position in shares of DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after acquiring an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA in the third quarter valued at $27,000. LRI Investments LLC boosted its position in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 564 shares during the period. Rothschild Investment LLC purchased a new position in shares of DENTSPLY SIRONA during the second quarter valued at $32,000. Finally, Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA during the third quarter valued at $35,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $17.87 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 1-year low of $17.21 and a 1-year high of $37.60. The firm’s fifty day simple moving average is $24.21 and its 200-day simple moving average is $25.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business’s revenue was up .4% compared to the same quarter last year. During the same period last year, the company earned $0.49 earnings per share. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on XRAY shares. Needham & Company LLC decreased their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Robert W. Baird decreased their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Finally, StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Wednesday, November 6th. Six analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.